Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)

Hyundai Bioscience Revenue

Hyundai Bioscience had revenue of 324.68M KRW in the quarter ending March 31, 2026, a decrease of -54.19%. This brings the company's revenue in the last twelve months to 3.13B, down -70.74% year-over-year. In the year 2025, Hyundai Bioscience had annual revenue of 3.52B, down -76.63%.

• Revenue (ttm): 3.13B
• Revenue Growth: -70.74%
• P/S Ratio: 274.43
• Revenue / Employee: 45.41M
• Employees: 69
• Market Cap: 859.84B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.52B	-11.53B	-76.63%
Dec 31, 2024	15.05B	5.57B	58.73%
Dec 31, 2023	9.48B	1.63B	20.76%
Dec 31, 2022	7.85B	-1.39B	-15.04%
Dec 31, 2021	9.24B	-3.27B	-26.14%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 9, 2026

Data Sources Report a data error